Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Xenics is a Belgium-based infrared imaging company that designs, manufactures, and markets infrared sensors, camera cores, and cameras for industrial, scientific, security, transportation, process monitoring, and medical imaging applications. The company is best known for short-wave, mid-wave, and long-wave infrared imaging products rather than therapeutics or drug development. Founded in 2000 in Leuven, Xenics became part of Photonis Group through a 2022 acquisition and now operates as a product brand within Exosens following the group's 2023 rebranding. Its offerings support advanced imaging use cases across machine vision and research markets, and the business is commercially focused with launched hardware products rather than a clinical pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Xenics.